FeesSafety
Pluang+

Choice Hotels beats Q3 EPS estimates, shows growth post-Harvest Hosts acquisition but faces regulatory risks.

Analyst Insights
09 Nov 2026, 09:13 WIB
Seeking Alpha
View Source
Neutral
Choice Hotels beats Q3 EPS estimates, shows growth post-Harvest Hosts acquisition but faces regulatory risks.

Choice Hotels International reported strong third-quarter results, surpassing earnings per share expectations and showing operational momentum following its acquisition of Harvest Hosts. The company's CEO is focused on strengthening franchise operations, maintaining an asset-light business model, and growing U.S. hotel room supply, with room growth expected to improve to about 1% year-over-year in the fourth quarter. However, potential challenges include regulatory risks from political changes that could affect revenue per available room (RevPAR) and limited margin safety at current stock prices. The analyst downgraded the stock to 'Hold' with a price target of around $123.30, preferring to wait for clearer signs on room growth and regulatory impacts before recommending a buy.

Choice Hotels International's recent operational momentum is set against a backdrop where only 27 of 134 Consumer Cyclical-sector US stocks traded on Pluang rose today. For readers following this sector, here is Pluang's market snapshot as of Nov 09, 2026 11:21 WIB: Expedia Group Inc (EXPE) dropped 17.70% to USD 259.97 with a typical hold time of 48 days, Mercadolibre Inc (MELI) fell 12.66% to USD 1,519.57 with a typical hold time of 119 days, and Abercrombie & Fitch Co. (ANF) declined 12.37% to USD 149.92 with a typical hold time of 67 days.

More News

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis Holding AG announced an in-person and virtual R&D Day on December 8, 2026, to highlight key clinical developments in its late-stage pipeline, including Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmology and neurology. The...

Market News
Bullish
23 minutes ago
DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA announced that its offer to acquire Capricorn Energy plc has lapsed as of November 9, 2026. This means the acquisition attempt will not proceed, impacting DNO's expansion plans in the oil and gas sector. Investors should monitor DNO's next st...

Market News
Neutral
23 minutes ago
Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis Holding AG will hold a Research & Development Day on December 8, 2026, to present key clinical progress on its late-stage drug candidates Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmic conditions including optic neuritis...

Company Fundamentals
Bullish
23 minutes ago
Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.

Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.

Juniper Research forecasts that losses from fraudulent robocalls in North America will decrease by 33%, from $18.4 billion in 2026 to $12.3 billion in 2031. This decline is attributed to telecom operators adopting advanced fraud prevention technologi...

Market News
Bullish
23 minutes ago
Bitcoin ETFs see $1.28B outflows amid strong US jobs data and crypto regulation uncertainty

Bitcoin ETFs see $1.28B outflows amid strong US jobs data and crypto regulation uncertainty

US spot Bitcoin ETFs experienced $1.28 billion in net outflows during the week ending November 6, driven largely by BlackRock's iShares Bitcoin Trust withdrawals. This decline reflects weaker institutional demand and rising Treasury yields, compounde...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App